Director of Neuroscience at Recursion leading development of human iPSC-derived cellular models for neurodegenerative disease drug discovery. Combines scientific leadership with hands-on execution, managing cross-functional teams and advancing programs from target identification through lead optimization.
The Impact You’ll Make:
Recursion is seeking a Director of Neuroscience to lead the development and application of human iPSC-derived cellular models for neurodegenerative disease drug discovery. This role combines scientific leadership with hands-on execution to advance programs from target identification through lead optimization. You will partner cross-functionally and with external collaborators to deliver high-quality, data-driven insights that accelerate therapeutic discovery.
Reporting to the Vice President of Neuroscience, you will be joining Recursion’s partnership with Roche-Genentech as a key leader. In this role, you will lead a team dedicated to the building of novel technology and projects in neurodegenerative diseases, exploring Recursion’s maps to decode novel neurobiology. This team exploits a multi-omic approach toward the establishment and validation of novel hypotheses in neuroscience disease biology while incorporating functionally relevant translational endpoints.
Working Location & Compensation:
This is an office and lab-based, hybrid role in our Salt Lake City, UT office. Employees are expected to work in the office at least 50% of the time.
At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is $198,000-237,600 (USD). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.
The Values We Hope You Share:
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.